HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 227 filers reported holding HORIZON PHARMA PLC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $333,000 | +60.9% | 12,615 | +19.1% | 0.01% | +50.0% |
Q4 2018 | $207,000 | +5.1% | 10,592 | +5.1% | 0.00% | 0.0% |
Q3 2018 | $197,000 | +18.0% | 10,080 | -0.0% | 0.00% | +33.3% |
Q2 2018 | $167,000 | +16.8% | 10,085 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $143,000 | +4666.7% | 10,085 | +3261.7% | 0.00% | – |
Q2 2017 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | – |
Q1 2017 | $4,000 | -92.0% | 300 | -90.5% | 0.00% | -100.0% |
Q4 2016 | $50,000 | -10.7% | 3,150 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $56,000 | -18.8% | 3,150 | -26.6% | 0.00% | -50.0% |
Q2 2016 | $69,000 | -51.4% | 4,289 | -50.5% | 0.00% | -50.0% |
Q1 2016 | $142,000 | -74.6% | 8,663 | -66.4% | 0.00% | -77.8% |
Q4 2015 | $559,000 | -12.7% | 25,820 | -20.1% | 0.02% | -18.2% |
Q3 2015 | $640,000 | -35.4% | 32,296 | +13.1% | 0.02% | -33.3% |
Q2 2015 | $991,000 | +35.0% | 28,555 | +1.0% | 0.03% | +37.5% |
Q1 2015 | $734,000 | +22.1% | 28,275 | -39.5% | 0.02% | +20.0% |
Q4 2014 | $601,000 | +7.3% | 46,700 | +2.3% | 0.02% | +5.3% |
Q3 2014 | $560,000 | – | 45,645 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |